Parathyroid hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle

Circulation

Volumn 110, Issue 2, 2004, Pages 177-185

  Fiaschi Taesch, Nathalie ^a   Takane, Karen K ^a   Masters, Sophia ^a   Lopez Talavera, Juan Carlos ^a   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Muscle, smooth; Neointima; Proteins; Restenosis

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; RETINOBLASTOMA PROTEIN; SERINE; SIGNAL PEPTIDE; THREONINE;

ADENOVIRUS; ANGIOPLASTY; ANIMAL CELL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; AUTOCRINE EFFECT; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSLATION INITIATION;

ADENOVIRIDAE; ANGIOPLASTY, BALLOON; ANIMALS; AORTA, THORACIC; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL CYCLE; CELL DIVISION; CELL LINE; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; TRANSFECTION;

EID: 3142782107     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000134483.30849.B7     Document Type: Article

References (30)

1. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol. 2000;18:1181-1184.
2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
3. Philbrick WM, Wysolmerski JJ, Galbraith S, et al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev. 1996;76:127-173.
4. Massfelder T, Helwig JJ. Parathyroid hormone-related protein in cardiovascular development and blood pressure regulation. Endocrinology. 1999;140:1507-1510.
5. Clemens TL, Cormier S, Eichinger A, et al. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol. 2001;134:1113-1136.
6. Karaplis AC, Luz A, Glowacki J, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 1994;8:277-289.
7. Ozeki S, Ohtsuru A, Seto S, et al. Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis: increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Arterioscler Thromb Vasc Biol. 1996;16:565-575.
8. Nakayama T, Ohtsuru A, Enomoto H, et al. Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem Biophys Res Commun. 1994;200:1028-1035.
9. Bakre MM, Zhu Y, Yin H, et al. Parathyroid hormone-related protein is a naturally occurring protein kinase A-dependent angiogenesis inhibitor. Nat Med. 2002;8:995-1003.
10. Maeda S, Sutliff RL, Qian J, et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology. 1999;140:1815-1825.
11. Qian J, Lorenz JN, Maeda S, et al. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology. 1999;140:1826-1833.
12. Massfelder T, Dann P, Wu TL, et al. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci U S A. 1997;94:13630-13635.
13. de Miguel F, Fiaschi-Taesch N, Lopez-Talavera JC, et al. The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology. 2001;142:4096-4105.
14. Nguyen MT, Karaplis AC. The nucleus: a target site for parathyroid hormone-related peptide (PTHrP) action. J Cell Biochem. 1998;70:193-199.
15. 85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem. 1999;274:18559-18566.
16. Lam MHC, Briggs LJ, Hu W, et al. Importin β recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin α. J Biol Chem. 1999;274:7391-7398.
17. Nguyen M, He B, Karaplis A. Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology. 2001;142:694-703.
18. Stuart WD, Maeda S, Khera P, et al. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. Am J Physiol. 2000;279:E60-E67.
19. Garcia-Ocana A, Takane KK, Reddy VT, et al. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem. 2003;278:343-351.
20. Becker TC, Noel RJ, Coats WS, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 1994;43:161-189.
21. Fenton AJ, Kemp BE, Hammonds RG Jr, et al. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP(107-111). Endocrinology. 1991;129:3424-3426.
22. De Miguel F, Martinez-Fernandez P, Guillen C, et al. Parathyroid hormone-related protein (107-139) stimulates interleukin-6 expression in human osteoblastic cells. J Am Soc Nephrol. 1999;10:796-803.
23. Valin A, Garcia-Ocana A, De Miguel F, et al. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells. J Cell Physiol. 1997;170:209-215.
24. Fenton AJ, Kemp BE, Kent GN, et al. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology. 1991;129:1762-1768.
25. Whitfield JF, Isaacs RJ, Jouishomme H, et al. C-terminal fragment of parathyroid hormone-related protein, PTHrP-(107-111), stimulates membrane-associated protein kinase C activity and modulates the proliferation of human and murine skin keratinocytes. J Cell Physiol. 1996;166:1-11.
26. Aarts MM, Davidson D, Corluka A, et al. Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem. 2001;276:37934-37943.
27. Conlan LA, Martin TJ, Gillespie MT. The COOH-terminus of parathyroid hormone-related protein (PTHrP) interacts with beta-arrestin. FEBS Lett. 2002;527:71-75.
28. Ishikawa M, Akishita M, Kozaki K, et al. Expression of parathyroid hormone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening. Atherosclerosis. 2000;152:97-105.
29. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
30. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56:139-145.